InvestorsHub Logo
icon url

BuyOnDips

02/13/13 4:09 PM

#3109 RE: umiak #3108

Thats some huge numbers! With Cardnial they are ready to roll out with the new drug as soon as the FDA gives the Okay.
icon url

umiak

02/13/13 4:10 PM

#3110 RE: umiak #3108

About NAV4694: Based on the data accumulated to date, AZD4694 appears to have very high sensitivity for detecting deposits of amyloid plaque in the brain. Due to its higher affinity for amyloid, markedly improved contrast has been observed displayed by an enhanced uptake in the amyloid-target regions of interest in the brain compared to background. The uptake in background tissue, referred to as white matter, is essentially negligible, providing optimized signal-to-noise ratios. Greater sensitivity and contrast may allow detection of smaller amounts of amyloid and may enable earlier identification of disease pathology.

http://www.navidea.com/development-programs/azd4694.html
icon url

sts66

02/13/13 7:53 PM

#3115 RE: umiak #3108

But how far away from commercializing it are they? A big unknown right now...I've been planning on selling ~ 1/2 my shares if we hit $6+, will almost recover my initial cash outlay at that pps, then let the rest ride, although if great news comes more rapidly than I expect that plan may change. These days biotechs are in a weird place - one of the most risky sectors in many ways, but also one of the safest if the economy blows up - people don't stop getting sick ;-)